Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis - Top-Institutions - MDSpire

Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis

  • By

  • Mariusz Ciołkiewicz

  • Anna Kuryliszyn-Moskal

  • Ewa Jabłońska

  • Wioletta Ratajczak-Wrona

  • Jacek Janica

  • Włodzimierz Samborski

  • Piotr A. Klimiuk

  • May 29, 2026

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, Maryland

    Key Differentiators

    • Rheumatology

  • #2

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Rheumatology

Original Source(s)

Liver steatosis, selected organokines, and cardiovascular risk markers in rheumatoid arthritis

  • by Mariusz Ciołkiewicz, Anna Kuryliszyn-Moskal, Ewa Jabłońska, Wioletta Ratajczak-Wrona, Jacek Janica, Włodzimierz Samborski, Piotr A. Klimiuk

  • May 29, 2026

Related Content

Deviation from physiologically appropriate oxygen levels alters proliferation, cytokine production and proximal antigen receptor signalling in CD4+ memory T cells

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra

Successful treatment of refractory focal eosinophilic myositis with extra-ocular muscle involvement using tocilizumab: a case report